Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,954 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study.
Hori H, Kudoh T, Nishimura S, Oda M, Yoshida M, Hara J, Tawa A, Usami I, Tanizawa A, Yumura-Yagi K, Kato K, Kobayashi R, Komada Y, Matsuo K, Horibe K; Japan Association of Childhood Leukemia Study. Hori H, et al. Among authors: kato k. Int J Clin Oncol. 2017 Apr;22(2):387-396. doi: 10.1007/s10147-016-1062-1. Epub 2016 Nov 17. Int J Clin Oncol. 2017. PMID: 27858183 Clinical Trial.
Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol.
Suzuki N, Yumura-Yagi K, Yoshida M, Hara J, Nishimura S, Kudoh T, Tawa A, Usami I, Tanizawa A, Hori H, Ito Y, Miyaji R, Oda M, Kato K, Hamamoto K, Osugi Y, Hashii Y, Nakahata T, Horibe K; Japan Association of Childhood Leukemia Study (JACLS). Suzuki N, et al. Among authors: kato k. Pediatr Blood Cancer. 2010 Jan;54(1):71-8. doi: 10.1002/pbc.22217. Pediatr Blood Cancer. 2010. PMID: 19813250
IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan.
Asai D, Imamura T, Suenobu S, Saito A, Hasegawa D, Deguchi T, Hashii Y, Matsumoto K, Kawasaki H, Hori H, Iguchi A, Kosaka Y, Kato K, Horibe K, Yumura-Yagi K, Hara J, Oda M; Japan Association of Childhood Leukemia Study (JACLS). Asai D, et al. Among authors: kato k. Cancer Med. 2013 Jun;2(3):412-9. doi: 10.1002/cam4.87. Epub 2013 May 9. Cancer Med. 2013. PMID: 23930217 Free PMC article.
Protracted Administration of L-Asparaginase in Maintenance Phase Is the Risk Factor for Hyperglycemia in Older Patients with Pediatric Acute Lymphoblastic Leukemia.
Yoshida H, Imamura T, Saito AM, Takahashi Y, Suenobu S, Hasegawa D, Deguchi T, Hashii Y, Kawasaki H, Endo M, Hori H, Suzuki N, Kosaka Y, Kato K, Yumura-Yagi K, Hara J, Oda M, Sato A, Horibe K; Japan Association of Childhood Leukemia Study. Yoshida H, et al. Among authors: kato k. PLoS One. 2015 Aug 28;10(8):e0136428. doi: 10.1371/journal.pone.0136428. eCollection 2015. PLoS One. 2015. PMID: 26317422 Free PMC article. Clinical Trial.
Long-term Results of the Risk-adapted Treatment for Childhood B-Cell Acute Lymphoblastic Leukemia: Report From the Japan Association of Childhood Leukemia Study ALL-97 Trial.
Horibe K, Yumura-Yagi K, Kudoh T, Nishimura S, Oda M, Yoshida M, Komada Y, Hara J, Tawa A, Usami I, Tanizawa A, Kato K, Kobayashi R, Matsuo K, Hori H; Japan Association of Childhood Leukemia Study (JACLS), Japan. Horibe K, et al. Among authors: kato k. J Pediatr Hematol Oncol. 2017 Mar;39(2):81-89. doi: 10.1097/MPH.0000000000000760. J Pediatr Hematol Oncol. 2017. PMID: 28169879 Clinical Trial.
Low Incidence of Osteonecrosis in Childhood Acute Lymphoblastic Leukemia Treated With ALL-97 and ALL-02 Study of Japan Association of Childhood Leukemia Study Group.
Sakamoto K, Imamura T, Kihira K, Suzuki K, Ishida H, Morita H, Kanno M, Mori T, Hiramatsu H, Matsubara K, Terui K, Takahashi Y, Suenobu SI, Hasegawa D, Kosaka Y, Kato K, Moriya-Saito A, Sato A, Kawasaki H, Yumura-Yagi K, Hara J, Hori H, Horibe K. Sakamoto K, et al. Among authors: kato k. J Clin Oncol. 2018 Mar 20;36(9):900-907. doi: 10.1200/JCO.2017.75.5066. Epub 2018 Jan 23. J Clin Oncol. 2018. PMID: 29360413
Discontinuation of L-asparaginase and poor response to prednisolone are associated with poor outcome of ETV6-RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia.
Usami I, Imamura T, Takahashi Y, Suenobu SI, Hasegawa D, Hashii Y, Deguchi T, Hori T, Shimada A, Kato K, Ito E, Moriya-Saito A, Kawasaki H, Hori H, Yumura-Yagi K, Hara J, Sato A, Horibe K; Japan Association of Childhood Leukemia Study Group (JACLS). Usami I, et al. Among authors: kato k. Int J Hematol. 2019 Apr;109(4):477-482. doi: 10.1007/s12185-019-02599-w. Epub 2019 Jan 28. Int J Hematol. 2019. PMID: 30689137
Risk-adjusted therapy for pediatric non-T cell ALL improves outcomes for standard risk patients: results of JACLS ALL-02.
Hasegawa D, Imamura T, Yumura-Yagi K, Takahashi Y, Usami I, Suenobu SI, Nishimura S, Suzuki N, Hashii Y, Deguchi T, Moriya-Saito A, Kato K, Kosaka Y, Hirayama M, Iguchi A, Kawasaki H, Hori H, Sato A, Kudoh T, Nakahata T, Oda M, Hara J, Horibe K; Japan Association of Childhood Leukemia Study Group (JACLS). Hasegawa D, et al. Among authors: kato k. Blood Cancer J. 2020 Feb 27;10(2):23. doi: 10.1038/s41408-020-0287-4. Blood Cancer J. 2020. PMID: 32107374 Free PMC article. Clinical Trial.
Outcome in 146 patients with paediatric acute myeloid leukaemia treated according to the AML99 protocol in the period 2003-06 from the Japan Association of Childhood Leukaemia Study.
Imamura T, Iwamoto S, Kanai R, Shimada A, Terui K, Osugi Y, Kobayashi R, Tawa A, Kosaka Y, Kato K, Hori H, Horibe K, Oda M, Adachi S; Japan Association of Childhood Leukaemia Study. Imamura T, et al. Among authors: kato k. Br J Haematol. 2012 Oct;159(2):204-10. doi: 10.1111/bjh.12030. Epub 2012 Aug 28. Br J Haematol. 2012. PMID: 22924344 Free article. Clinical Trial.
Inferior outcomes of stage III T lymphoblastic lymphoma relative to stage IV lymphoma and T-acute lymphoblastic leukemia: long-term comparison of outcomes in the JACLS NHL T-98 and ALL T-97 protocols.
Kobayashi R, Takimoto T, Nakazawa A, Fujita N, Akazai A, Yamato K, Yazaki M, Deguchi T, Hashii Y, Kato K, Hatakeyama N, Horibe K, Hori H, Oda M; Lymphoma Committee, Japanese Association of Childhood Leukemia Study. Kobayashi R, et al. Among authors: kato k. Int J Hematol. 2014 Jun;99(6):743-9. doi: 10.1007/s12185-014-1585-z. Epub 2014 May 7. Int J Hematol. 2014. PMID: 24803201
9,954 results